Allergan Plc

( )
AGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Generic
AGNAllergan Plc 1.82%176.152.9%$905.10m
ZTSZoetis, Inc. 4.48%116.781.9%$456.55m
TEVATeva Pharmaceutical Industries Ltd. 12.70%8.522.0%$203.77m
MYLMylan NV 1.28%15.073.2%$150.41m
BBIOBridgeBio Pharma, Inc. 0.00%26.670.0%$48.83m
RDYDr. Reddy's Laboratories Ltd. 4.30%40.252.0%$9.36m
TXMDTherapeuticsMD, Inc. -0.93%1.0722.2%$4.84m
COCPCocrystal Pharma, Inc. -6.18%0.720.0%$4.33m
TAROTaro Pharmaceutical Industries Ltd. 5.22%62.456.5%$4.21m
ABEOAbeona Therapeutics, Inc. -0.97%2.044.5%$3.35m
CPHIChina Pharma Holdings, Inc. 7.05%0.670.1%$2.72m
LFVNLifeVantage Corp. 4.50%10.683.3%$1.13m
KINKindred Biosciences, Inc. -4.17%3.910.3%$1.01m
JAGXJaguar Health, Inc. 0.19%0.532.2%$0.18m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.